pubmed.ncbi.nlm.nih.gov

Broadly altered gene expression in blood leukocytes in essential hypertension is absent during treatment - PubMed

Broadly altered gene expression in blood leukocytes in essential hypertension is absent during treatment

Helena Chon et al. Hypertension. 2004 May.

Abstract

We assessed whether large-scale expression profiling of leukocytes of patients with essential hypertension reflects characteristics of systemic disease and whether such changes are responsive to antihypertensive therapy. Total RNA from leukocytes were obtained from untreated (n=6) and treated (n=6) hypertensive patients without apparent end-organ damage and from normotensive controls (n=9). RNA was reverse-transcribed and labeled and gene expression analyzed using a 19-K oligonucleotide microarray using dye swaps. Samples of untreated and of treated patients were pooled for each sex and compared with age- and sex-matched controls. In untreated patients, 680 genes were differentially regulated (314 up and 366 down). In the treated patients, these changes were virtually absent (4 genes up, 3 genes down). A myriad of changes was observed in pathways involved in inflammation. Inflammation-dampening interleukin receptors were decreased in expression. Intriguingly, inhibitors of cytokine signaling (the PIAS family of proteins) were differentially expressed. The expression of several genes that are involved in regulation of blood pressure were also differentially expressed: angiotensin II type 1 receptor, ANP-A receptor, endothelin-2, and 3 of the serotonin receptors were increased, whereas endothelin-converting enzyme-1 was decreased. Strikingly, virtually no changes in gene expression could be detected in hypertensive patients who had become normotensive with treatment. This observation substantiates the long-standing idea that hypertension is associated with a complex systemic response involving inflammation-related genes. Furthermore, leukocytes display differential gene expression that is of importance in blood pressure control. Importantly, treatment of blood pressure to normal values can virtually correct such disturbances.

PubMed Disclaimer

Cited by

Transcriptomic biomarkers of cardiovascular disease.
Pedrotty DM, Morley MP, Cappola TP. Pedrotty DM, et al. Prog Cardiovasc Dis. 2012 Jul-Aug;55(1):64-9. doi: 10.1016/j.pcad.2012.06.003. Prog Cardiovasc Dis. 2012. PMID: 22824111 Free PMC article. Review.
Primary hypertension is a disease of premature vascular aging associated with neuro-immuno-metabolic abnormalities.
Litwin M, Feber J, Niemirska A, Michałkiewicz J. Litwin M, et al. Pediatr Nephrol. 2016 Feb;31(2):185-94. doi: 10.1007/s00467-015-3065-y. Epub 2015 Feb 28. Pediatr Nephrol. 2016. PMID: 25724169 Free PMC article. Review.
Cardiometabolic risk factors are associated with immune cell mitochondrial respiration in humans.
DeConne TM, Muñoz ER, Sanjana F, Hobson JC, Martens CR. DeConne TM, et al. Am J Physiol Heart Circ Physiol. 2020 Aug 1;319(2):H481-H487. doi: 10.1152/ajpheart.00434.2020. Epub 2020 Jul 17. Am J Physiol Heart Circ Physiol. 2020. PMID: 32678706 Free PMC article.
Peripheral blood gene expression profiling for cardiovascular disease assessment.
Aziz H, Zaas A, Ginsburg GS. Aziz H, et al. Genomic Med. 2007;1(3-4):105-12. doi: 10.1007/s11568-008-9017-x. Epub 2008 Feb 27. Genomic Med. 2007. PMID: 18923935 Free PMC article.
Prediction of ischemic events on the basis of transcriptomic and genomic profiling in patients undergoing carotid endarterectomy.
Folkersen L, Persson J, Ekstrand J, Agardh HE, Hansson GK, Gabrielsen A, Hedin U, Paulsson-Berne G. Folkersen L, et al. Mol Med. 2012 May 9;18(1):669-75. doi: 10.2119/molmed.2011.00479. Mol Med. 2012. PMID: 22371308 Free PMC article.

Broadly altered gene expression in blood leukocytes in essential hypertension is absent during treatment - PubMed